New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer.
This publication is a focused review of contemporary evidence guiding multimodality treatment in potentially curable pan...
Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
This study assessed the safety and feasibility of two neoadjuvant chemotherapy regimens—gemcitabine plus nab-paclitaxe...
Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer treated primarily with chemotherapy, but current regim...
Development and Prospective Validation of a Cell-free DNA-based Model for the Early Detection of Pancreatic Cancer.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
This study reports the development and validation of a non-invasive circulating cell-free DNA (cfDNA)-based model for ea...
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis, primarily due to late diagnos...
Preoperative prediction of early recurrence in pancreatic cancer: A novel clinical-radiomics model.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
The study (DOI: 10.1002/ijc.70142) developed and validated a preoperative prediction model for early postoperative recur...